ArticleJournal of oncology2022
AHCYL1 Is a Novel Biomarker for Predicting Prognosis and Immunotherapy Response in Colorectal Cancer.
Xubin Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleJournal of oncology2022
Xubin Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.